stocks logo

DCTH

Delcath Systems Inc
$
11.010
-0.990(-8.250%)
  • Overview
  • Forecast
  • Valuation
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
11.610
Open
11.370
VWAP
10.92
Vol
642.32K
Mkt Cap
368.09M
Low
10.575
Amount
7.01M
EV/EBITDA(TTM)
--
Total Shares
27.79M
EV
371.99M
EV/OCF(TTM)
--
P/S(TTM)
10.06

Delcath Systems, Inc. is an interventional oncology company. The Company is focused on the treatment of primary and metastatic liver cancers. The Company’s proprietary products, HEPZATO Kit (melphalan hydrochloride for Injection/Hepatic Delivery Syst...Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
FY2025Q2
FY2025Q3
16.83M
+436.1%
--
--
19.24M
+147.69%
--
--
22.17M
+97.98%
--
--
Estimates Revision
The market is revisingUpwardthe revenue expectations for Delcath Systems, Inc. (DCTH) for FY2025, with the revenue forecasts being adjusted by 12.45%over the past three months. During the same period, the stock price has changed by-13.03%.
Revenue Estimates for FY2025
Revise Upward
up Image
+12.45%
In Past 3 Month
Stock Price
Go Down
down Image
-13.03%
In Past 3 Month
4 Analyst Rating
up Image
99.82% Upside
Wall Street analysts forecast DCTH stock price to riseover the next 12 months. According to Wall Street analysts, the average 1-year price target for DCTH is 22.00USD with a low forecast of21.00USD and a high forecast of24.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
0 Hold
0 Sell
Strong Buy
up Image
99.82% Upside
Current: 11.010
sliders
Low
21.00
Averages
22.00
High
24.00
HC Wainwright & Co.
Swayampakula Ramakanth
Strong Buy
Maintains
$22 → $24
2025-03-07
Reason
Craig-Hallum
Chase Knickerbocker
Strong Buy
Maintains
$18 → $21
2025-01-17
Reason
HC Wainwright & Co.
Swayampakula Ramakanth
Strong Buy
Reiterates
$22
2025-01-14
Reason
HC Wainwright & Co.
Swayampakula Ramakanth
Strong Buy
Reiterates
$22
2024-11-11
Reason
HC Wainwright & Co.
Swayampakula Ramakanth
Strong Buy
Reiterates
$22
2024-10-18
Reason
Canaccord Genuity
John Newman
Strong Buy
Maintains
$21
2024-10-18
Reason
Stephens & Co.
Sudan Loganathan
Buy
Reiterates
$25
2024-08-06
Reason
HC Wainwright & Co.
Swayampakula Ramakanth
Strong Buy
Reiterates
$22
2024-08-06
Reason
Craig-Hallum
Chase Knickerbocker
Strong Buy
Initiates
$18
2024-06-28
Reason
HC Wainwright & Co.
Swayampakula Ramakanth
Strong Buy
Maintains
$20 → $22
2024-05-15
Reason

Valuation Metrics

The current forward P/E ratio for Delcath Systems Inc(DCTH.O) is -227.81, compared to its 5-year average forward P/E of -13.01. For a more detailed relative valuation and DCF analysis to assess Delcath Systems Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-13.01
Current PE
-227.81
Overvalued PE
28.92
Undervalued PE
-54.94

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-7.93
Current EV/EBITDA
19.36
Overvalued EV/EBITDA
19.64
Undervalued EV/EBITDA
-35.49

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
16.85
Current PS
4.40
Overvalued PS
32.62
Undervalued PS
1.08

Financials

Annual
Quarterly
FY2024Q4
YoY :
+2701.48%
15.10M
Total Revenue
FY2024Q4
YoY :
-126.88%
3.04M
Operating Profit
FY2024Q4
YoY :
-69.49%
-3.40M
Net Income after Tax
FY2024Q4
YoY :
-77.08%
-0.11
EPS - Diluted
FY2024Q3
YoY :
-57.91%
-3.86M
Free Cash Flow
FY2024Q3
YoY :
+23.09%
85.36
Gross Profit Margin - %
FY2024Q3
YoY :
-91.78%
-115.71
FCF Margin - %
FY2024Q3
YoY :
-100.36%
16.64
Net Margin - %

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 276.68% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
2
851.0K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

DCTH News & Events

Events Timeline
2025-03-06 (ET)
2025-03-06
08:12:17
Delcath Systems reports Q4 EPS (11c), consensus 1c
select
2025-01-13 (ET)
2025-01-13
07:16:38
Delcath Systems sees FY24 revenue $37.2M, consensus $34.52M
select
2025-01-13
07:14:11
Delcath Systems sees Q4 revenue $15.1M, consensus $12.42M
select
2024-12-02 (ET)
2024-12-02
07:59:05
FDA finishes review of Delcath's IND application of HEPZATO combo trial
select
2024-11-08 (ET)
2024-11-08
07:07:02
Delcath Systems reports Q3 EPS 6c, consensus (20c)
select
2024-10-17 (ET)
2024-10-17
08:42:43
Delcath Systems sees Q3 revenue $11.2M, consensus $9.45M
select
2024-08-27 (ET)
2024-08-27
08:58:34
Delcath Systems announces outcomes from independent study on PHP
select
News
5.0
03-27Newsfilter
Beta Bionics Announces Board Appointment of Gerard Michel
5.0
03-14Businesswire
Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
4.5
03-13SeekingAlpha
Stock selloff slashes needed-market cap for new Russell 2000 additions: Stephens
9.5
03-06Businesswire
Delcath Systems Reports Fourth Quarter and Full Year 2024 Results
3.0
03-05SeekingAlpha
Here's the major earnings before the open tomorrow
3.0
03-04NASDAQ.COM
Delcath Systems Q4 24 Earnings Conference Call At 8:30 AM ET
9.0
02-14Businesswire
Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma
2.0
02-10NASDAQ.COM
Delcath Delivers 100% Gain In Less Than 6 Months
7.0
01-31Yahoo Finance
Biotech walks a 'tightrope' amid unclear funding, regulations
1.0
01-28Yahoo Finance
Delcath Systems to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
5.0
01-26Yahoo Finance
retail investors who own 58% along with institutions invested in Delcath Systems, Inc. (NASDAQ:DCTH) saw increase in their holdings value last week
4.0
01-14Benzinga
HC Wainwright & Co. Reiterates Buy on Delcath Systems, Maintains $22 Price Target
9.5
01-13Investing.com
Delcath stock soars on Q4 and 2024 revenue beat By Investing.com
5.0
01-03Businesswire
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
8.5
2024-12-30Newsfilter
Delcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant Exercises
2.0
2024-12-26Benzinga
Why Zoomcar Shares Are Trading Higher By Around 142%; Here Are 20 Stocks Moving Premarket
5.0
2024-12-17Newsfilter
Clear Street Launches Healthcare & Biotechnology Equity Research
9.0
2024-12-02Newsfilter
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer
4.0
2024-11-11Benzinga
HC Wainwright & Co. Reiterates Buy on Delcath Systems, Maintains $22 Price Target
9.5
2024-11-09Yahoo Finance
Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

FAQ

arrow icon

What is Delcath Systems Inc (DCTH) stock price today?

The current price of DCTH is 11.01 USD — it hasdecreased-8.25 % in the last trading day.

arrow icon

What is Delcath Systems Inc (DCTH)'s business?

arrow icon

What is the price predicton of DCTH Stock?

arrow icon

What is Delcath Systems Inc (DCTH)'s revenue for the last quarter?

arrow icon

What is Delcath Systems Inc (DCTH)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Delcath Systems Inc (DCTH)'s fundamentals?

arrow icon

How many employees does Delcath Systems Inc (DCTH). have?

arrow icon

What is Delcath Systems Inc (DCTH) market cap?